Antiparasitic compounds that target DNA

Biochimie

Volumn 90, Issue 7, 2008, Pages 999-1014

  Wilson, W David ^a   Tanious, Farial A ^a   Mathis, Amanda ^b   Tevis, Denise ^a   Hall, James Edwin ^b   Boykin, David W ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiparasitic drugs; DNA binding; DNA topology; Heterocyclic diamidines; Kinetoplast DNA

Indexed keywords

ANTIPARASITIC AGENT; DIAMIDINE DERIVATIVE; MITOCHONDRIAL DNA; PENTAMIDINE;

CELL DEATH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; DNA BINDING; GENE TARGETING; KINETOPLAST; NONHUMAN; REVIEW;

ANIMALS; ANTIPARASITIC AGENTS; DNA, PROTOZOAN; DRUG DELIVERY SYSTEMS; HETEROCYCLIC COMPOUNDS; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; PENTAMIDINE; PROTOZOA;

EUKARYOTA;

EID: 45849096432     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.02.017     Document Type: Review

References (85)

1. Watkins B.M. Drugs for the control of parasitic diseases: current status and development. Trends Parasitol. 19 (2003) 477-478
2. World Health Organization. African Trypanosomiasis, Research Results: Nos. 1, 6. and 7, Fact Sheet Number 259 (2001), World Health Organization Publications, Geneva
3. Hutchinson O.C., Picozzi K., Jones N.G., Mott H., Sharma R., Welburn S.C., and Carrington M. Variant surface glycoprotein gene repertoires in Trypanosoma brucei have diverged to become strain-specific. BMC Genomics 8 (2007) 234-243
4. Vincendeau P., and Bouteille B. Immunology and immunopathology of African trypanosomiasis. An. Acad. Bras. Cienc. 78 (2006) 645-665
5. Barrett M.P., Boykin D.W., Brun R., and Tidwell R.R. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br. J. Pharmacol. 152 (2007) 1155-1171
6. Barrett M.P., Burchmore R.J., Stich A., Lazzari J.O., Frasch A.C., Cazzulo J.J., and Krishna S. The trypanosomiases. Lancet 362 (2003) 1469-1480
7. Bouteille B., Oukem O., Bisser S., and Dumas M. Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. 17 (2003) 171-181
8. Bray P.G., Barrett M.P., Ward S.A., and de Koning H.P. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. 19 (2003) 232-239
9. Bakshi R.P., and Shapiro T.A. DNA topoisomerases as targets for antiprotozoal therapy. Mini Rev. Med. Chem. 3 (2003) 597-608
10. Tidwell R.R., and Boykin D.W. In: Demeunynck M., Bailly C., and Wilson W.D. (Eds). DNA and RNA Binders: From Small Molecules to Drugs vol. 2 (2003), Wiley-VCH, Weinheim 414-460
11. Delespaux V., and de Koning H.P. Drug and drug resistance in African trypanosomiasis. Drug Resist. Updat. 10 (2007) 30-50
12. Glikson M., Dresner-Feigin R., Pollack A., Wolf D., Galun E., and Kaspa R.T. Pentamidine-induced cardiotoxicity. Isr. J. Med. Sci. 26 (1990) 588-589
13. Coyle P., Carr A.D., Depczynski B.B., and Chisholm D.J. Diabetes mellitus associated with pentamidine use in HIV-infected patients. Med. J. Aust. 165 (1996) 587-588
14. Kuryshev Y.A., Ficker E., Wang L., Hawryluk P., Dennis A.T., Wible B.A., Brown A.M., Kang J., Chen X.L., Sawamura K., Reynolds W., and Rampe D. Pentamidine-induced long QT syndrome and block of hERG trafficking. J. Pharmacol. Exp. Ther. 312 (2005) 316-323
15. Milligan K.S., and Phillips D.L. Perioral numbness associated with intravenous pentamidine administration. Ann. Pharmacother. 41 (2007) 153-156
16. Berger B.J., Lombardy R.J., Marbury G.D., Bell C.A., Dyksytra C.C., Hall J.E., and Tidwell R.R. Metabolic N-hydroxylation of pentamidine in vivo. Antimicrob. Agents Chemother. 34 (1990) 1678-1684
17. Berger B.J., Naiman N.A., Hall J.E., Peggins J., Brewer T.G., and Tidwell R.R. Primary and secondary metabolism of pentamidine by rats. Antimicrob. Agents Chemother. 36 (1992) 1825-1831
18. Wilson W.D., Tanious F.A., Buczak H., Venkatramanan M.K., Das B.P., and Boykin D.W. In: Pullman B., and Jortner J. (Eds). Molecular Basis of Specificity in Nucleic Acid-Drug Interactions (1990), Kluwer Academic Publishers 331-353
19. Waring M.J., and Bailly C. The influence of the exocyclic amino group characteristic of GC base pairs on molecular recognition of specific nucleotide sequences in DNA by berenil and DAPI. J. Mol. Recog. 10 (1997) 121-127
20. Neidle S. DNA minor-groove recognition by small molecules. Nat. Prod. Rep. 18 (2001) 291-309
21. Reddy B.S., Sondhi S.M., and Lown J.W. Synthetic DNA minor groove-binding drugs. Pharmacol. Ther. 84 (1999) 1-111
22. Geierstanger B.H., and Wemmer D.E. Complexes of the minor groove of DNA. Annu. Rev. Biophys. Biomol. Struct. 24 (1995) 463-493
23. Turner P.R., and Denny W.A. The genome as a drug target: sequence specific minor groove binding ligands. Curr. Drug Targets 1 (2000) 1-14
24. Cory M., Tidwell R.R., and Fairley T.A. Structure and DNA binding activity of analogues of 1,5-bis(4- amidinophenoxy)pentane (pentamidine). J. Med. Chem. 35 (1992) 431-438
25. Edwards K.J., Jenkins T.C., and Neidle S. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. Biochemistry 31 (1992) 7104-7109
26. Hamelberg D., Williams L.D., and Wilson W.D. Influence of the dynamic positions of cations on the structure of the DNA minor groove: sequence-dependent effects. J. Am. Chem. Soc. 123 (2001) 7745-7755
27. Bloomfield V.A., Crothers D.M., and Tinoco Jr. I. Nucleic Acids: Structures, Properties, and Functions (2000), University Science Books, Sausalito, CA
28. Brown D.G., Sanderson M.R., Skelly J.V., Jenkins T.C., Brown T., Garman E., Stuart D.I., and Neidle S. Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J. 9 (1990) 1329-1334
29. Pilch D.S., Kirolos M.A., Liu X., Plum G.E., and Breslauer K.J. Berenil [1,3-bis(4′-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties. Biochemistry 34 (1995) 9962-9976
30. Baraldi P.G., Bovero A., Fruttarolo F., Preti D., Tabrizi M.A., Pavani M.G., and Romagnoli R. DNA minor groove binders as potential antitumor and antimicrobial agents. Med. Res. Rev. 24 (2004) 475-528
31. Ismail M.A., Brun R., Easterbrook J.D., Tanious F.A., Wilson W.D., and Boykin D.W. Synthesis and antiprotozoal activity of aza-analogues of furamidine. J. Med. Chem. 46 (2003) 4761-4769
32. Shapiro T.A., and Englund P.T. The structure and replication of kinetoplast DNA. Annu. Rev. Microbiol. 49 (1995) 117-143
33. Klingbeil M.M., Drew M.E., Liu Y., Morris J.C., Motyka S.A., Saxowsky T.T., Wang Z., and Englund P.T. Unlocking the secrets of trypanosome kinetoplast DNA network replication. Protist 152 (2001) 255-262
34. Simpson L. Kinetoplast DNA in trypanosomid flagellates. Int. Rev. Cytol. 99 (1986) 119-179
35. Estevez A.M., and Simpson L. Uridine insertion/deletion RNA editing in trypanosome mitochondria - a review. Gene 240 (1999) 247-260
36. Madison-Antenucci S., Grams J., and Hajduk S.L. Editing machines: the complexities of trypanosome RNA editing. Cell 108 (2002) 435-438
37. Marini J.C., Levene S.D., Crothers D.M., and Englund P.T. A bent helix in kinetoplast DNA. Cold Spring Harb. Symp. Quant. Biol. 47 Pt. 1 (1983) 279-283
38. Marini J.C., Effron P.N., Goodman T.C., Singleton C.K., Wells R.D., Wartell R.M., and Englund P.T. Physical characterization of a kinetoplast DNA fragment with unusual properties. J. Biol. Chem. 259 (1984) 8974-8979
39. Mathis A.M., Holman J.L., Sturk L.M., Ismail M.A., Boykin D.W., Tidwell R.R., and Hall J.E. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrob. Agents Chemother. 50 (2006) 2185-2191
40. Matovu E., Stewart M.L., Geiser F., Brun R., Maser P., Wallace L.J., Burchmore R.J., Enyaru J.C., Barrett M.P., Kaminsky R., Seebeck T., and de Koning H.P. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot. Cell 2 (2003) 1003-1008
41. Carter N.S., Berger B.J., and Fairlamb A.H. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270 (1995) 28153-28157
42. de Koning H.P. Uptake of pentamidine in Trypanosoma brucie brucei is mediated by three distinct transporters: implication for cross-resistance with arsenicals. Mol. Pharmacol. 59 (2001) 586-592
43. Mathis A.M., Bridges A.S., Ismail M.A., Kumar A., Francesconi I., Anbazhagan M., Hu Q., Tanious F.A., Wenzler T., Saulter J., Wilson W.D., Brun R., Boykin D.W., Tidwell R.R., and Hall J.E. Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes. Antimicrob. Agents Chemother. 51 (2007) 2801-2810
44. Wilson W.D., Nguyen B., Tanious F.A., Mathis A., Hall J.E., Stephens C.E., and Boykin D.W. Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. Curr. Med. Chem. Anti-Cancer Agents 5 (2005) 389-408
45. Mukherjee A., Padmanabhan P.K., Sahani M.H., Barrett M.P., and Madhubala R. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani. Mol. Biochem. Parasitol. 145 (2006) 1-10
46. Das B.P., and Boykin D.W. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans. J. Med. Chem. 20 (1977) 531-536
47. Boykin D.W., Kumar A., Bender B.C., Hall J.E., and Tidwell R.R. Anti-Pneumocystis activity of bis-amidoximes and bis-O-alkylamidoximes. Bioorg. Med. Chem. Lett. 6 (1996) 3017-3020
48. Wilson W.D., Tanious F.A., Ding D., Kumar A., Boykin D.W., Colson P., Houssier C., and Bailly C. Nucleic acid interactions of unfused aromatic cations: evaluation of proposed minor-groove, major-groove, and intercalation binding modes. J. Am. Chem. Soc. 120 (1998) 10310-10321
49. Nguyen B., Tanious F.A., and Wilson W.D. Biosensor-surface plasmon resonance: quantitative analysis of small molecule-nucleic acid interactions. Methods 42 (2007) 150-161
50. Tanious F.A., Nguyen B., and Wilson W.D. Biosensor-surface plasmon resonance methods for quantitative analysis of biomolecular interactions. In: Correia J., and Detrich III H.W. (Eds). Methods in Cell Biology vol. 84 (2008), Elsevier Inc., New York 53-77 Chap. 3
51. Mazur S., Tanious F.A., Ding D., Kumar A., Boykin D.W., Simpson I.J., Neidle S., and Wilson W.D. A thermodynamic and structural analysis of DNA minor-groove complex formation. J. Mol. Biol. 300 (2000) 321-337
52. Liu Y., Kumar A., Boykin D.W., and Wilson W.D. Sequence and length dependent thermodynamic differences in heterocyclic diamidine interactions at AT base pairs in the DNA minor groove. Biophys. Chem. 131 (2007) 1-14
53. Laughton C.A., Tanious F., Nunn C.M., Boykin D.W., Wilson W.D., and Neidle S. A crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue of berenil. Structural origins of enhanced DNA-binding affinity, Biochemistry 35 (1996) 5655-5661
54. Degtyareva N.N., Wallace B.D., Bryant A.R., Loo K.M., and Petty J.T. Hydration changes accompanying the binding of minor groove ligands with DNA. Biophys. J. 92 (2007) 959-965
55. Ansede J.H., Voyksner R.D., Ismail M.A., Boykin D.W., Tidwell R.R., and Hall J.E. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis. Xenobiotica 35 (2005) 211-226
56. Wilson W.D., Tanious F.A., Fernandez-Saiz M., and Rigl C.T. Evaluation of drug-nucleic acid interactions by thermal melting curves. Methods Mol. Biol. 90 (1997) 219-240
57. Nguyen B., Tardy C., Bailly C., Colson P., Houssier C., Kumar A., Boykin D.W., and Wilson W.D. Influence of compound structure on affinity, sequence selectivity, and mode of binding to DNA for unfused aromatic dications related to furamidine. Biopolymers 63 (2002) 281-297
58. Oszczapowicz J. In: Patai S. (Ed). The Chemistry of Amidines and Imidates vol. 2 (1991), John Wiley & Sons, Chichester 623-688
59. Lamb I.D., and White A.C. Some amidines and amide oximes with trypanocidal activity. J. Chem. Soc. (1939) 1253-1257
60. Clement B., Immel M., Terlinden R., and Wingen F.J. Reduction of amidoxime derivatives to pentamidine in vivo. Arch. Pharm. 325 (1992) 61-62
61. Clement B. Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as prodrugs of amidines drug metabolism. Drug Metab. Rev. 34 (2002) 565-579
62. Hall J.E., Kerrigan J.E., Ramachandran K., Bender B.C., Stanko J.P., Jones S.K., Patrick D.A., and Tidwell R.R. Anti-Pneumocystis activities of aromatic diamidoxime prodrugs. Antimicrob. Agents Chemother. 42 (1998) 666-674
63. Soeiro M.N.C., de Souza E.M., Stephens C.E., and Boykin D.W. Aromatic diamidines as antiparasitic agents. Expert Opin. Invest. Drugs 14 (2005) 957-972
64. Werbovetz K.A. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Curr. Opin. Invest. Drugs 7 (2006) 147-157
65. Ansede J.H., Anbazhagan M., Brun R., Easterbrook J., Hall J.E., and Boykin D.W. O-Alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection. J. Med Chem. 47 (2004) 4335-4338
66. Zhou L., Voyksner R.D., Thakker D.R., Stephens C.E., Anbazhagan M., Boykin D.W., Hall J.E., and Tidwell R.R. Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 39 (2004) 351-360
67. 5 reductase. Drug Metab. Dispos. 33 (2005) 1886-1893
68. Patrick D.A., Hall J.E., Bender B.C., McCurdy D.R., Wilson W.D., Tanious F.A., Saha S., and Tidwell R.R. Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and orally active prodrugs. Eur. J. Med. Chem. 34 (1999) 575-583
69. Wang S., Hall J.E., Tanious F.A., Wilson W.D., Patrick D.A., McCurdy D.R., Bender B.C., and Tidwell R.R. Dicaionic dibenzofuran derivatives as anti-Pneumocystis carinii pneumonia agents: synthesis, DNA binding affinity, and anti-P. carinii activity in an immunosuppressed rat model. Eur. J. Med. Chem. 34 (1999) 215-224
70. Ismail M.A., Arafa R.K., Brun R., Wenzler T., Miao Y., Wilson W.D., Generaux C., Bridges A., Hall J.E., and Boykin D.W. Synthesis, DNA affinity, and antiprotozoal activity of linear dications: Terphenyl diamidines and analogues. J. Med. Chem. 49 (2006) 5324-5332
71. Clement B., Burenheide A., Rieckert W., and Schwarz J. Diacetyldiamidoxime ester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation. Chem. Med. Chem. 1 (2006) 1260-1267
72. Ouattara M., Wein S., Calas M., Hoang Y.V., Vial H., and Esacle R. Synthesis and antimalarial activity of new 1,12-bis-(N,N′-acetamidinyl)dodecane derivatives. Bioorg. Med. Chem. Lett. 17 (2007) 593-596
73. Rahmathullah S.M., Hall J.E., Bender B.C., McCurdy D.R., Tidwell R.R., and Boykin D.W. Prodrugs for amidines: synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-bis(4-amidinophenyl)furan. J. Med. Chem. 42 (1999) 3994-4000
74. Boykin D.W., Kumar A., Xiao G., Wilson W.D., Bender B.C., McCurdy D.R., Hall J.E., and Tidwell R.R. 2,5-bis[4-(N-Alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents. J. Med. Chem. 41 (1998) 124-129
75. Rahmathullah S.M., Tidwell R.R., Jones S.K., Hall J.E., and Boykin D.W. Carbamate prodrugs of N-alkylfuramidines. Eur. J. Med. Chem. 43 (2008) 174-177
76. Wang L., Bailly C., Kumar A., Ding D., Bajic M., Boykin D.W., and Wilson W.D. Specific molecular recognition of mixed nucleic acid sequences: an aromatic dication that binds in the DNA minor groove as a dimer. Proc. Natl. Acad. Sci. USA 97 (2000) 12-16
77. Bailly C., Tardy C., Wang L., Armitage B., Hopkins K., Kumar A., Schuster G.B., Boykin D.W., and Wilson W.D. Recognition of ATGA sequences by the unfused aromatic dication db293 forming stacked dimers in the DNA minor groove. Biochemistry 40 (2001) 9770-9779
78. Tanious F., Wilson W.D., Wang L., Kumar A., Boykin D.W., Marty C., Baldeyrou B., and Bailly C. Cooperative dimerization of a heterocyclic diamidine determines sequence-specific DNA recognition. Biochemistry 46 (2003) 13576-13586
79. Wang L., Carrasco C., Kumar A., Stephens C.E., Bailly C., Boykin D.W., and Wilson W.D. Evaluation of the influence of compound structure on stacked-dimer formation in the DNA minor groove. Biochemistry 40 (2001) 2511-2521
80. Munde M., Lee M., Neidle S., Arafa R., Boykin D.W., Liu Y., Bailly C., and Wilson W.D. Induced fit conformational changes of a "reversed amidine" heterocycle: optimized interactions in a DNA minor groove complex. J. Am. Chem. Soc. 129 (2007) 5688-5698
81. Nguyen B., Lee M.P.H., Hamelberg D., Joubert A., Bailly C., Brun R., Neidle S., and Wilson W.D. Strong binding in the DNA minor groove by an aromatic diamidine with a shape that does not match the curvature of the groove. J. Am. Chem. Soc. 124 (2002) 13680-13681
82. Miao Y., Lee M.P., Parkinson G.N., Batista-Parra A., Ismail M.A., Neidle S., Boykin D.W., and Wilson W.D. Out of-shape DNA minor groove binders: induced fit interactions of heterocyclic dications with the DNA minor groove. Biochemistry 44 (2005) 14701-14708
83. Hardwidge P.R., Den R.B., Ross E.D., and Maher III L.J. Relating independent measures of DNA curvature: electrophoretic anomaly and cyclization efficiency. J. Biomol. Struct. Dyn. 18 (2000) 219-230
84. Hardwidge P.R., and Maher L.J. Experimental evaluation of the Liu-Beveridge dinucleotide step model of DNA structure. Nucleic Acids Res. 29 (2001) 2619-2625
85. Ross E.D., Den R.B., Hardwidge P.R., and Maher III L.J. Improved quantitation of DNA curvature using ligation ladders. Nucleic Acids Res. 27 (1999) 4135-4142